VERONICA JAMES: Open Payments
NPI 1245768019 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 18 payments from 8 companies in 2025. Trend: 2023 $13 · 2024 $188 · 2025 $363
Food & beverage: $363
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $133 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Exact Sciences Corporation | 2 | $34 |
| INOGEN, INC. | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: REXULTI, CAPLYTA, ABILIFY ASIMTUFII, TRINTELLIX, Cologuard Collection Kit, INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH, INVEGA SUSTENNA, Auvelity.
Industry payments across NV — which companies pay providers there.
